Compare Abeona Therapeutics Inc (ABEO) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Star Bulk Carriers Corp — how do they compare? Abeona Therapeutics Inc trades at $6.76 (market cap $373.32M), while Star Bulk Carriers Corp trades at $26.3 (market cap $2.92B). The key difference: Star Bulk Carriers Corp is far larger — about 7.8× Abeona Therapeutics Inc's market cap, and Star Bulk Carriers Corp pays a 3.93% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | SBLK | |
|---|---|---|
Market Cap | $373.32M | $2.92B |
Sector | Health | Industrials |
52-Week High | $7.23 | $28.21 |
52-Week Low | $4.17 | $16.79 |
Enterprise Value | $228.22M | $3.62B |
Dividend Yield | — | 3.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Star Bulk Carriers (SBLK) trades at $26.12, up 3.86% with bullish technical signals and strong earnings momentum after beating Q1 2026 estimates. The company shows solid fundamentals with 13.01% net income margin and positive cash flow, supported by a new dividend policy returning 100% of free cash flow. Analyst consensus is strongly bullish with 14 buy ratings.
SBLK presents a compelling investment case with earnings growth acceleration and shareholder-friendly capital allocation. Key risks include dry bulk market volatility and oil price sensitivity, but strong institutional support and technical momentum suggest continued upside potential for disciplined investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
